Cargando…

Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis

BACKGROUND: The association between grip strength (GS) and non-alcoholic fatty liver disease (NAFLD) has been reported by recent epidemiological studies, however, the results of these studies are inconsistent. This meta-analysis was conducted to collect all available data and estimate the risk of NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Liu, Fu, Shifeng, Li, Jianglei, Liu, Deliang, Tan, Yuyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458919/ https://www.ncbi.nlm.nih.gov/pubmed/36091710 http://dx.doi.org/10.3389/fmed.2022.988566

Ejemplares similares

Longitudinal Associations Between Hand Grip Strength and Non-Alcoholic Fatty Liver Disease in Adults: A Prospective Cohort Study
por: Xia, Yang, et al.
Publicado: (2021)

Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
por: Li, Jianglei, et al.
Publicado: (2022)

Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases
por: Li, Jianglei, et al.
Publicado: (2022)

Reductions in liver cirrhosis hospitalizations during the COVID-19 pandemic
por: Li, Jianglei, et al.
Publicado: (2021)

Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults
por: Lee, Inhwan, et al.
Publicado: (2018)

Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease
por: Hao, Li, et al.
Publicado: (2020)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Risk Factors of Non-en Bloc Resection and Non-R0 Resection During Endoscopic Resection in the Treatment of Superficial Duodenal Epithelial Lesions
por: Fu, Shifeng, et al.
Publicado: (2022)

Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study
por: Kim, Beom-Jun, et al.
Publicado: (2019)

Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis
por: Alenezi, Yusef M, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
por: Wang, Meng, et al.
Publicado: (2022)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Luo, Qian, et al.
Publicado: (2022)

Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis
por: Lee, Shi-Yan, et al.
Publicado: (2022)

A Prospective Study of Grip Strength Trajectories and Incident Cardiovascular Disease
por: Liu, Weida, et al.
Publicado: (2021)

Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies
por: Mátis, Dóra, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults
por: Liu, Qi, et al.
Publicado: (2022)

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease
por: Ghevariya, Vishal, et al.
Publicado: (2014)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Alcohol consumption and risk of fatty liver disease: a meta-analysis
por: Cao, Guoli, et al.
Publicado: (2016)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Gosal, Harpreet, et al.
Publicado: (2021)

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
por: Wang, Huanqiu, et al.
Publicado: (2022)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease
por: Han, Juqiang, et al.
Publicado: (2021)

Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review
por: Kaur, Simran, et al.
Publicado: (2023)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
por: Santacroce, Giovanni, et al.
Publicado: (2023)

Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
por: Yang, Huan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6f3qq2lpdjumuud7vc0itp67k6